Skip to content

Middle ear pressuretreatment by EFET01 in patients with atypical Meniere's disease

Middle ear pressuretreatment by EFET01 in patients with atypical Meniere's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042230155
Enrollment
30
Registered
2024-02-19
Start date
2024-02-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atypical Meniere's disease Meniere's disease, Atypical case, EFET01, Middle ear pressure treatment

Interventions

Patient receives middle ear pressure treatment (MEPT) by EFET01 at home for 3 minutes per sesssion, twice a day. Vertigo symptom calendar is kept to record the level of vertigo, subjective distress a

Sponsors

Takakura Hiromasa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient aged between 18 and 80 years old 2) Untreated patient who was diagnosed as atypical Meniere's disease based on the Clinical practice guidelines for Meniere's disease and delayed endolymphatic hydrops 2020 3) Patient who understands treatment method and procedure and is able to agree in writing of his own free will 4) Patinet who can use EFET01 correctly at home 5) Patient that conservative treatment is invalid

Exclusion criteria

Exclusion criteria: 1) Patient using life support dispute 2) Patient using cardiac pacemarker and implantale defibrillator 3) Patient who has disase or injury in auricle and/or external auditory canal 4) Patient with tympanic membrane perforation 5) Patient unable to comply treatment method and procedure 6) Patient who was evaluated as ineligible person by doctor in charge

Design outcomes

Primary

MeasureTime frame
Number of vertigo attacks in 4 weeks based on vertigo symptom calendar

Secondary

MeasureTime frame
Lever of vertigo attacks, subjective distress and activity level in 4 weeks based on vertigo symptom calendar

Contacts

Public ContactHiromasa Takakura

University of Toyama

hiromasa@med.u-toyama.ac.jp+81-76-434-7368

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026